NCT00000950已完成不适用
Pharmacokinetics of Antituberculosis Agents in HIV-Infected Persons With Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID)23 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2001年8月31日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 50
- 试验地点
- 23
研究概览
简要总结
The purpose of this study is to determine if a relationship exists between the level of antituberculosis drugs (isoniazid, rifampin, ethambutol, and pyrazinamide) in the blood and the outcome of HIV-positive patients with tuberculosis. This study also evaluates how these drugs are absorbed and metabolized in the body.
详细描述
Patients receive up to 8 weeks of two or more anti-tuberculosis drugs, of which at least two are isoniazid, rifampin, pyrazinamide, or ethambutol. Blood specimens are collected at 2, 6, and 10 hours after administration of study medication, once between Days 10 and 14 of a phase of daily treatment and once while on an intermittent dose regimen (twice weekly or three times weekly).
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 13 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (23)
Loading locations...
相似试验
Unknown
4 期
Evaluation of the Pharmacokinetics of Antituberculosis Drugs and Tuberculosis Treatment OutcomesAIDS With TuberculosisNCT01782950Makerere University400
已完成
2 期
TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TBHIV InfectionsTuberculosisNCT00023348Centers for Disease Control and Prevention150
招募中
不适用
Population Pharmacokinetics of Anti-tuberculosis Drugs in Children With TuberculosisTuberculosisNCT03625739Beijing Children's Hospital800
终止
4 期
A Study to Determine the Best Dose of Antivirals in Patients With Both TB and HIVTuberculosisHIV InfectionsNCT00523458Stanford University5
已完成
1 期
Pharmacokinetic Interactions Between Antiretroviral Agents and Antimalarial Drug CombinationsMalariaHIV InfectionsNCT00697892Fran Aweeka38